Hemispherx Biopharma (HEB) Doubles Q1 Loss to 2c/Share

May 7, 2012 4:36 PM EDT
Hemispherx Biopharma, Inc. (NYSE: HEB) reported Q1 EPS of ($0.02), versus ($0.01) reported last year.

For earnings history and earnings-related data on Hemispherx Biopharma, Inc. (HEB) click here.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment